← SynDRA
DENFIVONTINIB
SynDRA canonical compound SYN0039914 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | FLT3 |
|---|
| Mechanism of action | tyrosine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- FLT3 INHIBITOR
- MERTK INHIBITOR
- tyrosine kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP2C9
- CP2D6
- CP3A7
- IP6K1
- JAK2
- NSD2
- TP53
Cross-references
Synonyms
- CPD 6
- G-749
- G749
- UNII-B06W426B66
- RefChem:131866
- G-801
- B06W426B66
- C25H25BrN6O2
- MFCD28167815
- Denfivontinib [INN]
- GTPL8108
- orb1305257
- SCHEMBL15265027
- SCHEMBL30471308
- BDBM756196
- GLXC-90053
- EX-A1074
- BDBM50422751
- s7545
- US12350272, Compound 226
- AKOS026750566
- CCG-269863
- CS-3343
- EBC-220145
- NCGC00386412-04
- AC-33000
- BS-15433
- DA-33613
- HY-12333
- G-749?
- F865648
- Denfivontinib (hydrochloride)
- SCHEMBL29624614
- US20250214997, Compound E-6
- HY-W400801
- SCHEMBL15264372
- G-749 hydrochloride
- UNII-01ZQ25VJAL
- orb1738883
Look up DENFIVONTINIB in the interactive SynDRA portal →